613 related articles for article (PubMed ID: 11532090)
41. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury.
Wang Z; Wei X; Zhang Y; Ma X; Li B; Zhang S; Du P; Zhang X; Yi F
Cell Physiol Biochem; 2009; 24(5-6):619-26. PubMed ID: 19910702
[TBL] [Abstract][Full Text] [Related]
42. Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis.
Eng DG; Sunseri MW; Kaverina NV; Roeder SS; Pippin JW; Shankland SJ
Kidney Int; 2015 Nov; 88(5):999-1012. PubMed ID: 25993321
[TBL] [Abstract][Full Text] [Related]
43. Puromycin aminonucleoside increases podocyte permeability by modulating ZO-1 in an oxidative stress-dependent manner.
Ha TS; Park HY; Seong SB; Ahn HY
Exp Cell Res; 2016 Jan; 340(1):139-49. PubMed ID: 26683996
[TBL] [Abstract][Full Text] [Related]
44. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
Yang HC; Ma LJ; Ma J; Fogo AB
Kidney Int; 2006 May; 69(10):1756-64. PubMed ID: 16598202
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.
Fukuda A; Wickman LT; Venkatareddy MP; Sato Y; Chowdhury MA; Wang SQ; Shedden KA; Dysko RC; Wiggins JE; Wiggins RC
Kidney Int; 2012 Jan; 81(1):40-55. PubMed ID: 21937979
[TBL] [Abstract][Full Text] [Related]
46. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis.
Asano T; Niimura F; Pastan I; Fogo AB; Ichikawa I; Matsusaka T
J Am Soc Nephrol; 2005 Aug; 16(8):2257-62. PubMed ID: 15987751
[TBL] [Abstract][Full Text] [Related]
47. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria.
Yu D; Petermann A; Kunter U; Rong S; Shankland SJ; Floege J
J Am Soc Nephrol; 2005 Jun; 16(6):1733-41. PubMed ID: 15829708
[TBL] [Abstract][Full Text] [Related]
48. Glomerular albumin filtration through podocyte cell body in puromycin aminonucleoside nephrotic rat.
Tojo A; Onozato ML; Kitiyakara C; Kinugasa S; Fukuda S; Sakai T; Fujita T
Med Mol Morphol; 2008 Jun; 41(2):92-8. PubMed ID: 18592163
[TBL] [Abstract][Full Text] [Related]
49. Increase in extracellular cross-linking by tissue transglutaminase and reduction in expression of MMP-9 contribute differentially to focal segmental glomerulosclerosis in rats.
Liu S; Li Y; Zhao H; Chen D; Huang Q; Wang S; Zou W; Zhang Y; Li X; Huang H
Mol Cell Biochem; 2006 Mar; 284(1-2):9-17. PubMed ID: 16477388
[TBL] [Abstract][Full Text] [Related]
50. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis.
Nagata M; Kriz W
Kidney Int; 1992 Jul; 42(1):148-60. PubMed ID: 1635344
[TBL] [Abstract][Full Text] [Related]
51. Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.
Liu S; Shi W; Xiao H; Liang X; Deng C; Ye Z; Mei P; Wang S; Liu X; Shan Z; Liang Y; Zhang B; Wang W; Liu Y; Xu L; Xia Y; Ma J; Li Z
PLoS One; 2012; 7(7):e41331. PubMed ID: 22848465
[TBL] [Abstract][Full Text] [Related]
52. In vitro effects of puromycin aminonucleoside on the ultrastructure of rat glomerular podocytes.
Bertram JF; Messina A; Ryan GB
Cell Tissue Res; 1990 May; 260(3):555-63. PubMed ID: 2372813
[TBL] [Abstract][Full Text] [Related]
53. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
54. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model.
Herrmann A; Tozzo E; Funk J
Exp Toxicol Pathol; 2012 Jan; 64(1-2):45-9. PubMed ID: 20591637
[TBL] [Abstract][Full Text] [Related]
55. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
56. Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease.
Pippin JW; Sparks MA; Glenn ST; Buitrago S; Coffman TM; Duffield JS; Gross KW; Shankland SJ
Am J Pathol; 2013 Aug; 183(2):542-57. PubMed ID: 23769837
[TBL] [Abstract][Full Text] [Related]
57. Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis.
Kriz W; Hähnel B; Rösener S; Elger M
Kidney Int; 1995 Nov; 48(5):1435-50. PubMed ID: 8544400
[TBL] [Abstract][Full Text] [Related]
58. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
[TBL] [Abstract][Full Text] [Related]
59. How many ways can a podocyte die?
Tharaux PL; Huber TB
Semin Nephrol; 2012 Jul; 32(4):394-404. PubMed ID: 22958494
[TBL] [Abstract][Full Text] [Related]
60. Urine podocyte mRNAs mark progression of renal disease.
Sato Y; Wharram BL; Lee SK; Wickman L; Goyal M; Venkatareddy M; Chang JW; Wiggins JE; Lienczewski C; Kretzler M; Wiggins RC
J Am Soc Nephrol; 2009 May; 20(5):1041-52. PubMed ID: 19389856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
